Fig. 4: Anticoagulation for patients with LVA and without a clear indication for anticoagulation. | Nature Communications

Fig. 4: Anticoagulation for patients with LVA and without a clear indication for anticoagulation.

From: Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study

Fig. 4

Kaplan-Meier event-free survival curve in patients with LVA and without a clear indication for anticoagulation according to anticoagulation status (without anticoagulant use: n = 641; with anticoagulant use: n = 112): A Net adverse clinical events (B) All-cause mortality (C) Systemic embolism events (D) Major bleeding events. Source data are provided as a Source Data file. Abbreviations: LVA left ventricular aneurysm.

Back to article page